Physician Research Collaboration is committed to enhancing patient treatment options for the future
3901 Pine Lake Road # 120
Lincoln, NE
68516
| Monday | 8am - 4pm |
| Tuesday | 8am - 4pm |
| Wednesday | 8am - 4pm |
| Thursday | 8am - 4pm |
| Friday | 8am - 12pm |
Be the first to know and let us send you an email when Physician Research Collaboration posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Physician Research Collaboration:
PRC was founded in 2006 from a 30 year private practice rheumatology research center to provide a turnkey approach and immediate profitability to other Physicians who desire to professionally conduct their own clinical research trials. PRC combines the expertise of private practice physicians and established patient populations with PRC’s vast research experience to provide sponsors with repetitive success in study enrollment, quality participants, clean data and timely completion of all aspects of the clinical research process.
PRC has three partner owners: Melvin A. Churchill, MD, Rick C. Chatwell, MD and Lisa M. Kastanek, RN, CCRC. Together they have over 90 cumulative years of clinical research experience, enrolled over 300 clinical trials, managed three routine Food and Drug Administration (FDA) audits and were found to be in compliance with the FDA’s Good Clinical Practice Guidelines on all three occasions.
PRC has provided research expertise to principal investigators in internal medicine, family practice and pediatrics giving these physicians the research tools necessary to be immediately successful at conducting clinical trials. PRC has provided physician investigators the ability to work with cutting edge scientific advances while providing patients an opportunity to participate in clinical trials that may offer new or better treatments while scientists collect data to search for cures. We are very proud to have participated in many exciting research opportunities that have resulted in the FDA approval of many currently marketed therapies for the treatment of rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus, gout, giant cell arteritis, polymyalgia rheumatic, vaccines, infant formula, attention deficit hyperactivity disorder, Down’s Syndrome, gastroesophageal reflux disease, diabetes, hypertension and chronic obstructive pulmonary disease.
Please contact us if you would like more information or desire to be a part of this exciting quest for improved medical care.
